These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8989544)
1. Detection of bladder tumor by urine cytology in cases of prostatic hypertrophy. Rammou-Kinia R; Anagnostopoulou I Diagn Cytopathol; 1996 Dec; 15(5):409-11. PubMed ID: 8989544 [TBL] [Abstract][Full Text] [Related]
2. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment. Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
6. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813 [TBL] [Abstract][Full Text] [Related]
7. Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma. Hakenberg OW; Fuessel S; Richter K; Froehner M; Oehlschlaeger S; Rathert P; Meye A; Wirth MP Urology; 2004 Dec; 64(6):1121-6. PubMed ID: 15596183 [TBL] [Abstract][Full Text] [Related]
8. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder. Shariat SF; Matsumoto K; Casella R; Jian W; Lerner SP Eur Urol; 2005 Jul; 48(1):69-76. PubMed ID: 15967254 [TBL] [Abstract][Full Text] [Related]
9. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Kumar A; Kumar R; Gupta NP Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
11. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder. Gupta NP; Sharma N; Kumar R Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205 [TBL] [Abstract][Full Text] [Related]
13. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method? Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859 [TBL] [Abstract][Full Text] [Related]
15. Value of urine cytology in screening patients with prostatitis syndromes. de la Rosette JJ; Hubregtse MR; Wiersma AM; Debruyne FM Acta Cytol; 1993; 37(5):710-2. PubMed ID: 8362583 [TBL] [Abstract][Full Text] [Related]
16. Urine cytology in the evaluation of urological malignancy revisited: is it still necessary? Falebita OA; Lee G; Sweeney P Urol Int; 2010; 84(1):45-9. PubMed ID: 20173368 [TBL] [Abstract][Full Text] [Related]
17. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer. Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079 [TBL] [Abstract][Full Text] [Related]
18. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder. Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567 [TBL] [Abstract][Full Text] [Related]
19. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison. Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562 [TBL] [Abstract][Full Text] [Related]
20. [Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma]. Wu DL; Zhang YF; Guan M; Liu WW; Xu YM; Jin SB; Zhang J; Jin CR; Lü Y Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):274-7. PubMed ID: 17760254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]